You are here

President Trump Uses Executive Order to Start Scaling Back Obamacare

Republicans ponder “repeal and replace” bill

In his first round of executive orders, President Donald Trump has instructed all federal agencies to “waive, defer, grant exemptions from, or delay” any part of the Patient Protection and Affordable Care Act (PPACA) that imposes a financial or regulatory burden, but the practical implications and potential fallout from the order are still unclear, according to a report from Kaiser Health News (KHN).

No confirmed secretaries or political appointees are in place at any of the relevant agencies, so it is unlikely that anything will happen in the near future, KHN says.

Last week, Trump told the Washington Post that he was putting finishing touches on a health plan that would guarantee “insurance for everybody.” Those comments, however, were quickly walked back by staff.

Meanwhile, the nomination of Trump’s choice to lead the Department of Health and Human Services, Representative Tom Price (R-Georgia), has been delayed by Democrats’ allegations of conflicts of interest involving his ownership of stocks in health companies while he served on congressional committees overseeing health issues.

Congress has already taken the first step toward overhauling the PPACA. Both the House and the Senate passed a budget resolution that orders committees to begin writing bills that would eliminate portions of the act that directly affect the budget.

But while a “repeal and replace” bill––which hasn’t been written yet––could pass the Senate with a 51-vote majority, Republicans have only 52 seats in the Senate, and some lawmakers have expressed reservations about repealing the PPACA without an immediate replacement.

House and Senate Republicans are scheduled to discuss the matter next week at a retreat in Philadelphia. Trump and Vice President Mike Pence are scheduled to attend.

Source: Kaiser Health News; January 20, 2107.

Recent Headlines

Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Despite older, sicker patients, mortality rate fell by a third in 10 years
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs